Q1 2025 Veracyte Inc Earnings Call Transcript

May 7, 2025 / 08:30 PM GMT

Release Date Price: $30.84 (+0.92%)

Transcript 10-Q8-K

Key Points

Positve

Veracyte Inc (VCYT) reported a strong Q1 2025 with total revenue of $114.5 million, marking an 18% year-over-year growth.
The company's core testing business showed robust performance with Decipher and Affirma delivering double-digit volume growth of 37% and 10% respectively.
Veracyte Inc (VCYT) ended the quarter with a strong balance sheet, holding $287 million in cash and short-term investments.
The company is making significant strides in expanding its product offerings, including the launch of Decipher for metastatic prostate cancer and the upcoming launch of ProSigna as an LDT for the US breast cancer market.
Veracyte Inc (VCYT) is focused on cost reduction initiatives, transitioning Affirma onto a more cost-effective sequencing technology, which is expected to offset future reagent price increases.

Negative

Revenue growth for Affirma was lower than volume growth due to prior period collection benefits and a lab benefit manager's mistaken coverage policy change.
The company is facing challenges with its French subsidiary, Veracyte SAS, which has filed for bankruptcy, impacting IVD product development timelines.
There is uncertainty around the impact of tariffs and potential price increases from vendors, which could affect future costs.
Veracyte Inc (VCYT) is still adjudicating some claims related to the lab benefit manager's coverage policy change, which may take another quarter or two to resolve.
The company's MRD platform, while promising, is still in the early stages with significant investment required to prove its value and achieve reimbursement.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VCYT.OQ - Veracyte Inc
Q1 2025 Veracyte Inc Earnings Call
May 07, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Verisite first quarter 2025 Financial results webcast. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised.

To withdraw your question, please press 11 again.

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Sheila Gorman, senior director at Investor Relations.

Please go ahead.

------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.